• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence and Incidence of Atrial Fibrillation Among Older Primary Care Patients.

作者信息

Khurshid Shaan, Ashburner Jeffrey M, Ellinor Patrick T, McManus David D, Atlas Steven J, Singer Daniel E, Lubitz Steven A

机构信息

Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston.

Cardiovascular Research Center, Massachusetts General Hospital, Boston.

出版信息

JAMA Netw Open. 2023 Feb 1;6(2):e2255838. doi: 10.1001/jamanetworkopen.2022.55838.

DOI:10.1001/jamanetworkopen.2022.55838
PMID:36780164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11015386/
Abstract
摘要

相似文献

1
Prevalence and Incidence of Atrial Fibrillation Among Older Primary Care Patients.老年初级保健患者心房颤动的患病率和发病率
JAMA Netw Open. 2023 Feb 1;6(2):e2255838. doi: 10.1001/jamanetworkopen.2022.55838.
2
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.一项针对65岁及以上人群检测心房颤动的系统筛查（针对性筛查和全人群筛查）与常规做法的随机对照试验及成本效益研究。SAFE研究。
Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74. doi: 10.3310/hta9400.
3
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care.基层医疗中房颤的发病率、患病率及死亡率的时间趋势
J Am Heart Assoc. 2017 Apr 28;6(5):e005155. doi: 10.1161/JAHA.116.005155.
4
Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland.芬兰心房颤动的全面全国发病率和患病率趋势。
Open Heart. 2022 Nov;9(2). doi: 10.1136/openhrt-2022-002140.
5
Prevalence, incidence, risk factors and treatment of atrial fibrillation in Australia: The Australian Diabetes, Obesity and Lifestyle (AusDiab) longitudinal, population cohort study.澳大利亚心房颤动的患病率、发病率、危险因素及治疗：澳大利亚糖尿病、肥胖与生活方式（AusDiab）纵向人群队列研究。
Int J Cardiol. 2016 Feb 15;205:127-132. doi: 10.1016/j.ijcard.2015.12.013. Epub 2015 Dec 15.
6
[Atrial fibrillation in medical intensive care unit patients: characteristics and consequences].[医学重症监护病房患者的心房颤动：特征与后果]
Harefuah. 2013 Sep;152(9):520-3, 564.
7
Incidence and predictors of atrial fibrillation and its impact on long-term survival in patients with supraventricular arrhythmias.房性心律失常患者心房颤动的发生率及预测因素及其对长期生存的影响。
Europace. 2014 Oct;16(10):1508-14. doi: 10.1093/europace/euu129. Epub 2014 Jun 6.
8
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor.通过筛查老年人未诊断出的房颤来减少中风（GUARD-AF）：基于14天贴片式连续心电图监测仪筛查房颤的GUARD-AF随机试验的原理与设计
Am Heart J. 2022 Jul;249:76-85. doi: 10.1016/j.ahj.2022.04.005. Epub 2022 Apr 25.
9
Atrial fibrillation: prevalence in a large database of primary care patients in Brazil.心房颤动：巴西大型基层医疗患者数据库中的患病率。
Europace. 2015 Dec;17(12):1787-90. doi: 10.1093/europace/euv185. Epub 2015 Jun 7.
10
Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden--a retrospective study of incidence and quality in a registered population.瑞典初级卫生保健中慢性房颤患者的抗凝治疗——对登记人群发病率和质量的回顾性研究
Fam Pract. 2004 Dec;21(6):612-6. doi: 10.1093/fampra/cmh606. Epub 2004 Oct 1.

引用本文的文献

1
Time's imprint on the left atrium: aging and atrial myopathy.时间在左心房留下的印记：衰老与心房肌病。
J Cardiovasc Aging. 2025 Jun;5(2). doi: 10.20517/jca.2024.23. Epub 2025 Mar 20.
2
Comparison of Safety and Effectiveness Between Direct Oral Anticoagulants and Vitamin K Antagonists in Dementia Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis.直接口服抗凝剂与维生素K拮抗剂在痴呆合并心房颤动患者中的安全性和有效性比较：一项系统评价和Meta分析
J Clin Med. 2025 Aug 14;14(16):5758. doi: 10.3390/jcm14165758.
3
Structure of Comorbidities and Causes of Death in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease.心房颤动合并慢性阻塞性肺疾病患者的共病结构及死亡原因
J Clin Med. 2025 Jul 16;14(14):5045. doi: 10.3390/jcm14145045.
4
The Use of Direct Oral Anticoagulants (DOACs) in the Geriatric Population-How to Overcome the Challenges of Geriatric Syndromes.老年人群中直接口服抗凝剂（DOACs）的应用——如何克服老年综合征带来的挑战
J Clin Med. 2025 Jun 20;14(13):4396. doi: 10.3390/jcm14134396.
5
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据：美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
6
Novel anticoagulation therapy using apple watch after catheter ablation for atrial fibrillation-Up to AF trial: Design and rationale.房颤导管消融术后使用苹果手表的新型抗凝治疗——“Up to AF”试验：设计与原理
J Arrhythm. 2024 Dec 5;41(1):e13194. doi: 10.1002/joa3.13194. eCollection 2025 Feb.
7
Prevalence, Management, and Comorbidities of Adults With Atrial Fibrillation in the United States, 2019 to 2023.2019年至2023年美国成人房颤的患病率、管理及合并症
JACC Adv. 2024 Oct 10;3(11):101330. doi: 10.1016/j.jacadv.2024.101330. eCollection 2024 Nov.
8
Multiclass arrhythmia classification using multimodal smartwatch photoplethysmography signals collected in real-life settings.使用在现实生活环境中收集的多模态智能手表光电容积脉搏波信号进行多类心律失常分类。
Res Sq. 2024 Dec 13:rs.3.rs-5463126. doi: 10.21203/rs.3.rs-5463126/v1.
9
Comparative effectiveness and safety of rivaroxaban with other oral anticoagulants in older adults with nonvalvular atrial fibrillation: population-based analysis in response to updated Beers Criteria.利伐沙班与其他口服抗凝剂在老年非瓣膜性心房颤动患者中的疗效及安全性比较：基于人群的分析以回应更新的Beers标准
J Thromb Haemost. 2025 Feb;23(2):546-555. doi: 10.1016/j.jtha.2024.10.009. Epub 2024 Oct 21.
10
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients.老年患者卵圆孔未闭封堵术后不良结局的决定因素。
EuroIntervention. 2024 Aug 19;20(16):1029-1038. doi: 10.4244/EIJ-D-24-00156.

本文引用的文献

1
Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial.初级保健就诊时对老年人进行房颤筛查：VITAL-AF随机对照试验
Circulation. 2022 Mar 29;145(13):946-954. doi: 10.1161/CIRCULATIONAHA.121.057014. Epub 2022 Mar 2.
2
Characteristics of Americans With Primary Care and Changes Over Time, 2002-2015.美国人的初级保健特征及其随时间的变化，2002-2015 年。
JAMA Intern Med. 2020 Mar 1;180(3):463-466. doi: 10.1001/jamainternmed.2019.6282.
3
Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants.与直接口服抗凝剂引入相关的基层医疗网络中房颤患者抗凝治疗使用情况的变化
Am J Cardiol. 2017 Sep 1;120(5):786-791. doi: 10.1016/j.amjcard.2017.05.055. Epub 2017 Jun 15.
4
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.弗雷明汉心脏研究中房颤患病率、发病率、危险因素及死亡率的50年趋势：一项队列研究
Lancet. 2015 Jul 11;386(9989):154-62. doi: 10.1016/S0140-6736(14)61774-8. Epub 2015 May 7.
5
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.1993 - 2007年医疗保险受益人心房颤动的发病率、患病率及相关死亡率
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93. doi: 10.1161/CIRCOUTCOMES.111.962688. Epub 2012 Jan 10.
6
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.心房颤动的患病率、发病率和终生风险：鹿特丹研究。
Eur Heart J. 2006 Apr;27(8):949-53. doi: 10.1093/eurheartj/ehi825. Epub 2006 Mar 9.